Form D · Biotechnology
Sharklet Technologies, Inc.
Aurora, CO · CIK 0001467750
Offering snapshot reported Dec 18, 2012 · SEC filing
- Reported sold
- $2M Offering amount: $2.13M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 18, 2012 | Initial | $2,004,554 | No comparison | 2 | SEC filing |
| Jul 7, 2009 | Initial | $1,170,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-188568
Source: Form D, filed Dec 18, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph W. Bagan | Director, Executive |
| Tony Brennan | Director |
| Anthony B. Brennan | Director |
| Greg Carlisle | Director |
| Greg Garvis | Director |
| Al Perkins | Director |
| Dan Seff | Director |
| Mark Spiecker | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12635 E. Montview Blvd., Suite 160
Aurora, CO, 80045
Aurora, CO, 80045